DE69510669D1 - Modifizierter wachstumsfaktor der milch - Google Patents

Modifizierter wachstumsfaktor der milch

Info

Publication number
DE69510669D1
DE69510669D1 DE69510669T DE69510669T DE69510669D1 DE 69510669 D1 DE69510669 D1 DE 69510669D1 DE 69510669 T DE69510669 T DE 69510669T DE 69510669 T DE69510669 T DE 69510669T DE 69510669 D1 DE69510669 D1 DE 69510669D1
Authority
DE
Germany
Prior art keywords
milk
growth factors
modified
product extract
approximately
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69510669T
Other languages
English (en)
Other versions
DE69510669T2 (de
Inventor
David Andrew Belford
Mary-Louise Rogers
Geoffrey Leonard Francis
Geoffrey Owen Regester
Geoffrey Welsford Smithers
Francis John Ballard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes Biopharma DK AS
Original Assignee
Gropep Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3779922&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69510669(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gropep Ltd filed Critical Gropep Ltd
Publication of DE69510669D1 publication Critical patent/DE69510669D1/de
Application granted granted Critical
Publication of DE69510669T2 publication Critical patent/DE69510669T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/205—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey from whey, e.g. lactalbumine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals
    • C12N2500/84—Undefined extracts from animals from mammals

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE69510669T 1994-04-28 1995-04-26 Modifizierter wachstumsfaktor der milch Expired - Lifetime DE69510669T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPM5347A AUPM534794A0 (en) 1994-04-28 1994-04-28 Modified milk growth factor
PCT/AU1995/000237 WO1995029933A1 (en) 1994-04-28 1995-04-26 Modified milk growth factor

Publications (2)

Publication Number Publication Date
DE69510669D1 true DE69510669D1 (de) 1999-08-12
DE69510669T2 DE69510669T2 (de) 1999-10-28

Family

ID=3779922

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69510669T Expired - Lifetime DE69510669T2 (de) 1994-04-28 1995-04-26 Modifizierter wachstumsfaktor der milch

Country Status (9)

Country Link
US (1) US6194208B1 (de)
EP (1) EP0759029B1 (de)
JP (1) JP3640965B2 (de)
AT (1) ATE181924T1 (de)
AU (1) AUPM534794A0 (de)
CA (1) CA2188654C (de)
DE (1) DE69510669T2 (de)
NZ (2) NZ284389A (de)
WO (1) WO1995029933A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN271295A0 (en) * 1995-05-02 1995-05-25 Gropep Pty Ltd Method of treatment
EP0894094B1 (de) * 1996-03-15 2005-05-11 BioEqual AG Verfahren zur gewinnung eines komplexes aus wachstumsfaktoren
US5772999A (en) * 1996-07-30 1998-06-30 Dcv Biologics, L.P. Method of preventing, countering, or reducing NSAID-induced gastrointestinal damage by administering milk or egg products from hyperimmunized animals
GB9619660D0 (en) * 1996-09-20 1996-11-06 Scient Hospital Suppl Int Ltd Prevention of gastrointestinal damage
NL1005677C2 (nl) * 1997-03-27 1998-09-29 Campina Melkunie Bv Werkwijze voor het winnen van groeifactoren, of een samenstelling die één of meer groeifactoren bevat, uit melk of een derivaat daarvan.
ES2139525B1 (es) * 1997-11-17 2000-10-16 Sanchez Pedro Cuevas Empleo de derivados del lactosuero como citoprotectores y cicatrizantes.
AUPQ878600A0 (en) * 2000-07-13 2000-08-03 Gropep Pty Ltd Compositions and methods for the treatment of intact skin
MXPA04002387A (es) * 2001-09-12 2004-11-22 Eastern Virginia Med School Factor inhibidor de afluencia de calcio y metodo de aislamiento del mismo.
GB0209384D0 (en) 2002-04-24 2002-06-05 Pepsyn Ltd Peptide composition
US20060240116A1 (en) * 2005-04-22 2006-10-26 David Jolley Bioactive factors in wound healing topical compositions and methods
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8075934B2 (en) 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US8350006B2 (en) * 2008-10-24 2013-01-08 Mead Johnson Nutrition Company Methods for determining the bioactivity of TGF-β in a composition
US8367354B2 (en) * 2008-10-24 2013-02-05 Mead Johnson Nutrition Company Methods for determining the levels of TGF-β in a composition
AU2013204850B2 (en) * 2012-10-08 2015-06-25 Murray Goulburn Co-Operative Co. Limited Improved process for purifying milk proteins and products thereof
KR102576778B1 (ko) * 2020-01-09 2023-09-12 세종대학교산학협력단 세포 배양용 소태아혈청 대체 소재
WO2023079080A1 (en) 2021-11-05 2023-05-11 Frieslandcampina Nederland B.V. Use of tgf in the prevention virus infection of the respiratory tract
WO2023127960A1 (ja) * 2021-12-28 2023-07-06 日本ハム株式会社 筋組織由来細胞の分化の抑制剤

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440860A (en) * 1980-01-18 1984-04-03 The Children's Medical Center Corporation Stimulating cell growth
IE54979B1 (en) * 1982-07-09 1990-04-11 Bridel Laiteries Process for treating milk with a cation-exchange resin for the preparation of decationised,acidified milk
WO1987001038A1 (en) 1985-08-22 1987-02-26 Commonwealth Scientific And Industrial Research Or Peptide analogues of mammalian insulin-like growth factor-1
GB8723094D0 (en) 1987-10-01 1987-11-04 Ciba Geigy Ag Polypeptide growth factor from milk
US5221734A (en) * 1987-10-01 1993-06-22 Ciba-Geigy Corporation Process for preparing a polypeptide growth factor for milk
DK513589A (da) 1988-10-20 1990-04-21 Smithkline Beecham Corp Human epitelcelleomdannende vaekstfaktor og fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende vaekstfaktoren
JPH03236772A (ja) * 1990-02-13 1991-10-22 Snow Brand Milk Prod Co Ltd 新規な細胞増殖促進物質及びこれを有効成分とする細胞培養培地添加物
FR2663816B1 (fr) * 1990-06-28 1993-08-06 Clar Procede de traitement du colostrum par chromatographie d'adsorption sur hydroxyapatite, fraction active de colostrum obtenue et milieu cellulaire contenant ladite fraction active.
EP0545946B1 (de) * 1990-07-13 2005-01-19 Gropep Limited Wachstumsfördernder wirkstoff
DE69128283T2 (de) 1991-08-12 1998-03-19 Nestle Sa Nahrungsmittelzusammensetzung
FI91166C (fi) 1991-10-17 1994-05-25 Valio Biotuotteet Oy Ternimaitofraktio, menetelmä sen valmistamiseksi ja sen käyttö kasvualustojen täydennysaineena
US5281582A (en) * 1992-02-27 1994-01-25 Alliance Pharmaceuticals, Corp. Serum growth factor
AU3903593A (en) * 1992-04-22 1993-11-18 Bopa Ireland Limited Products derived from whey and their use in foodstuffs
NL1005677C2 (nl) 1997-03-27 1998-09-29 Campina Melkunie Bv Werkwijze voor het winnen van groeifactoren, of een samenstelling die één of meer groeifactoren bevat, uit melk of een derivaat daarvan.

Also Published As

Publication number Publication date
US6194208B1 (en) 2001-02-27
EP0759029B1 (de) 1999-07-07
NZ284389A (en) 1997-04-24
EP0759029A4 (de) 1997-06-04
CA2188654C (en) 2007-04-24
DE69510669T2 (de) 1999-10-28
NZ314284A (en) 2000-06-23
ATE181924T1 (de) 1999-07-15
EP0759029A1 (de) 1997-02-26
JP3640965B2 (ja) 2005-04-20
JPH09512536A (ja) 1997-12-16
CA2188654A1 (en) 1995-11-09
AUPM534794A0 (en) 1994-05-19
WO1995029933A1 (en) 1995-11-09

Similar Documents

Publication Publication Date Title
DE69510669D1 (de) Modifizierter wachstumsfaktor der milch
FR2499990B1 (fr) Procede de preparation de derives d'acides quinoleinecarboxyliques, nouveaux produits ainsi obtenus et leur utilisation comme agents antibacteriens
ES8801986A1 (es) Un procedimiento para producir un gel o jugo de aloe sustancialmente exento de antraquinona.
DE69314810T2 (de) Verfahren zur herstellung von kaltwasserlöslichen und kältestabilem trinkfertigem tee und produkt
ES8500932A1 (es) Procedimiento para la obtencion de acidos quinoloncarboxilicos
ATA290483A (de) Verwendung von neuen 2-pyridylalkyl-sulfinylbenzimidazolen zur herstellung von die magensaeuresekretion beeinflussenden pharmazeutischen praeparaten
DE3679128D1 (de) Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben.
ATE13286T1 (de) Pharmazeutisch aktive phenylcarbonsaeurederivate.
HUT67436A (en) Process to prepare novel hydroxamic acid and n-hydroxyurea derivatives and pharmaceutical compn.s contg. them
IS1963B (is) Seyði úr hákarlabrjóski, aðferð við framleiðslu þess og notkun
ATE84721T1 (de) Physiologisch wirksame produkte, verfahren zur herstellung und zusammensetzung.
FR2541278B1 (fr) Procede de preparation de derives d'acide benzoquinolizinecarboxylique, nouveaux produits ainsi obtenus et leur utilisation comme agents antibacteriens
DE3778852D1 (de) Arzneimittel enthaltend das gewebeprotein pp4, verfahren zur herstellung von pp4 und zu seiner pasteurisierung sowie die verwendung von pp4.
NO20010940D0 (no) TAN-1057 derivater
FR2317924A1 (fr) Procede de production de derives d'ortho-aminobutyrophenone, nouveaux produits ainsi obtenus et leur utilisation comme agents analgesiques et antipsychose
DE69717843T2 (de) Cis-3,4-chromanderivate zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromen
ES2012128A6 (es) Metodo de tratar plantas con acidos organicos que contienen azufre.
ATE67175T1 (de) Verfahren zur herstellung von 6-alkoxy-5trifluormethyl-1-naphthoesaeuren und 1-cyanonaphthalenzwischenprodukten.
BE883576A (fr) Nouveaux derives d'hydroxyamino-eburnane leur procede de preparation, intermediaires utiles et utilisation comme medicament et comme intermediaire
DE69718500D1 (de) (-)-enantiomere von cis-3,4-chromanderivaten zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromen
MA20666A1 (fr) Esters nouveaux d'acides vinylcyclopropane-carboxyliques, leur procede de production et leur utilisation comme pesticides
FR2447927B1 (fr) Procede de preparation de polyphosphites aromatiques et nouveaux produits ainsi obtenus, employes comme anti-oxydants pour polymeres
DE3784308D1 (de) Verwendung von somatostatin zur herstellung eines arzneimittels fuer die behandlung von rheumatoider arthritis.
BE860956A (fr) Nouveaux halogenures d'esters d'acide dithiophosphorique, leur procede de preparation et leur application comme produits intermediaires
EP0137499A3 (de) Verfahren zur Gewinnung von beta-Elemonsäure und diese enthaltende pharmazeutische Zubereitungen

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: NOVOZYMES BIOPHARMA AU LTD., ADELAIDE, AU

8328 Change in the person/name/address of the agent

Representative=s name: WESTENDORP SOMMER, 80336 MUENCHEN

8327 Change in the person/name/address of the patent owner

Owner name: NOVOZYMES BIOPHARMA DK A/S, BAGSVAERD, DK

8328 Change in the person/name/address of the agent

Representative=s name: SPLANEMANN PATENT- UND RECHTSANWAELTE PARTNERSCHAF